Stocktoria
GT Biopharma, Inc. GTBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-10-22
GT Biopharma, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -349.8% | -311.0% | -53.8% | -124.8% | -180.3% |
| Return on equity | -490.0% | 788.1% | -101.6% | -178.0% | -264.8% |
| Current ratio | 3.50 | 0.72 | 2.12 | 3.35 | 3.14 |
Source: SEC EDGAR filings · CIK 0000109657 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.